SK283715B6 - Deriváty erytromycínu, spôsob a medziprodukty na ich prípravu, ich použitie ako liečiv a farmaceutické kompozície s ich obsahom - Google Patents

Deriváty erytromycínu, spôsob a medziprodukty na ich prípravu, ich použitie ako liečiv a farmaceutické kompozície s ich obsahom Download PDF

Info

Publication number
SK283715B6
SK283715B6 SK750-99A SK75099A SK283715B6 SK 283715 B6 SK283715 B6 SK 283715B6 SK 75099 A SK75099 A SK 75099A SK 283715 B6 SK283715 B6 SK 283715B6
Authority
SK
Slovakia
Prior art keywords
formula
methyl
erythromycin
optionally substituted
carbon atoms
Prior art date
Application number
SK750-99A
Other languages
English (en)
Slovak (sk)
Other versions
SK75099A3 (en
Inventor
Jean-Michel Auger (Zomrel)
Pierre Michel Auger (Dedi�)
Nicole No�Lle Dejean (Dedi�)
Constantin Agouridas
Catherine Domecq (Dedi�)
Jean-Fran�Ois Chant�T (Zomrel)
Paul Chantot Lucien (Dedi�)
Alexis Denis
Original Assignee
Aventis Pharma S. A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma S. A. filed Critical Aventis Pharma S. A.
Publication of SK75099A3 publication Critical patent/SK75099A3/sk
Publication of SK283715B6 publication Critical patent/SK283715B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
SK750-99A 1996-12-12 1997-12-10 Deriváty erytromycínu, spôsob a medziprodukty na ich prípravu, ich použitie ako liečiv a farmaceutické kompozície s ich obsahom SK283715B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9615271A FR2757168B1 (fr) 1996-12-12 1996-12-12 Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
PCT/FR1997/002254 WO1998025942A1 (fr) 1996-12-12 1997-12-10 Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments

Publications (2)

Publication Number Publication Date
SK75099A3 SK75099A3 (en) 2000-01-18
SK283715B6 true SK283715B6 (sk) 2003-12-02

Family

ID=9498593

Family Applications (1)

Application Number Title Priority Date Filing Date
SK750-99A SK283715B6 (sk) 1996-12-12 1997-12-10 Deriváty erytromycínu, spôsob a medziprodukty na ich prípravu, ich použitie ako liečiv a farmaceutické kompozície s ich obsahom

Country Status (28)

Country Link
EP (1) EP0946579B1 (es)
JP (1) JP4363666B2 (es)
KR (1) KR100490074B1 (es)
CN (2) CN100363375C (es)
AP (1) AP997A (es)
AT (1) ATE217008T1 (es)
AU (1) AU721732B2 (es)
BG (1) BG63124B1 (es)
BR (1) BR9714007A (es)
CA (1) CA2273985C (es)
CZ (1) CZ292403B6 (es)
DE (1) DE69712361T2 (es)
DK (1) DK0946579T3 (es)
EA (1) EA001733B1 (es)
ES (1) ES2174323T3 (es)
FR (1) FR2757168B1 (es)
GE (1) GEP20012518B (es)
HU (1) HUP0001180A3 (es)
ID (1) ID21873A (es)
IL (1) IL130420A (es)
NO (1) NO314040B1 (es)
NZ (1) NZ335325A (es)
PT (1) PT946579E (es)
SK (1) SK283715B6 (es)
TR (1) TR199901301T2 (es)
WO (1) WO1998025942A1 (es)
YU (1) YU25699A (es)
ZA (1) ZA9711101B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2771008B1 (fr) * 1997-11-17 2000-04-28 Hoechst Marion Roussel Inc Utilisation des ketolides pour la preparation de compositions pharmaceutiques destinees a prevenir les complications thrombotiques arterielles liees a l'atherosclerose
EP1137654A1 (en) * 1998-12-10 2001-10-04 Pfizer Products Inc. Carbamate and carbazate ketolide antibiotics
EP1147121B1 (en) 1999-01-27 2003-12-17 Pfizer Products Inc. Ketolide antibiotics
KR20020007374A (ko) * 1999-04-16 2002-01-26 추후제출 매크롤라이드 항감염제
WO2000071557A1 (en) 1999-05-24 2000-11-30 Pfizer Products Inc. 13-methyl-erythromycin derivatives
US6472372B1 (en) 2000-12-06 2002-10-29 Ortho-Mcneil Pharmaceuticals, Inc. 6-O-Carbamoyl ketolide antibacterials
DK200201957A (da) * 2002-12-20 2003-01-20 Alpharma Aps 10-substituted erythromycin ketolides and methods of making

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4742049A (en) * 1986-06-04 1988-05-03 Abbott Laboratories Semisynthetic erythromycin antibiotics
IL114589A (en) * 1990-11-21 1999-12-22 Roussel Uclaf Intermediates for the preparation of the history of erythromycin
KR0166996B1 (ko) * 1992-04-22 1999-01-15 우에하라 아키라 5-o-데소사미닐에리쓰로노라이드a 유도체
US5527780A (en) * 1992-11-05 1996-06-18 Roussel Uclaf Erythromycin derivatives
JP3709997B2 (ja) * 1994-03-29 2005-10-26 日東電工株式会社 耐熱性ネガ型フォトレジスト組成物および感光性基材、ならびにネガ型パターン形成方法
FR2718450B1 (fr) * 1994-04-08 1997-01-10 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2719587B1 (fr) * 1994-05-03 1996-07-12 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.

Also Published As

Publication number Publication date
CN100363375C (zh) 2008-01-23
EA001733B1 (ru) 2001-08-27
KR20000057517A (ko) 2000-09-15
EP0946579A1 (fr) 1999-10-06
EA199900528A1 (ru) 1999-12-29
ES2174323T3 (es) 2002-11-01
YU25699A (sh) 2002-06-19
CN1239966A (zh) 1999-12-29
AU721732B2 (en) 2000-07-13
GEP20012518B (en) 2001-08-27
CZ208299A3 (cs) 1999-09-15
JP4363666B2 (ja) 2009-11-11
CN1238364C (zh) 2006-01-25
IL130420A0 (en) 2000-06-01
TR199901301T2 (xx) 1999-08-23
CA2273985A1 (fr) 1998-06-18
EP0946579B1 (fr) 2002-05-02
HUP0001180A2 (hu) 2000-09-28
NZ335325A (en) 2000-08-25
BG103398A (en) 2000-01-31
BR9714007A (pt) 2000-05-09
ID21873A (id) 1999-08-05
AP9901513A0 (en) 1999-06-30
ATE217008T1 (de) 2002-05-15
BG63124B1 (bg) 2001-04-30
NO314040B1 (no) 2003-01-20
FR2757168A1 (fr) 1998-06-19
JP2001506620A (ja) 2001-05-22
WO1998025942A1 (fr) 1998-06-18
FR2757168B1 (fr) 1999-06-11
DE69712361D1 (de) 2002-06-06
CA2273985C (fr) 2007-03-20
AP997A (en) 2001-08-09
DK0946579T3 (da) 2002-08-12
AU5487798A (en) 1998-07-03
DE69712361T2 (de) 2002-11-28
KR100490074B1 (ko) 2005-05-17
PT946579E (pt) 2002-10-31
CZ292403B6 (cs) 2003-09-17
HUP0001180A3 (en) 2003-05-28
IL130420A (en) 2003-01-12
NO992859L (no) 1999-06-11
CN1721427A (zh) 2006-01-18
NO992859D0 (no) 1999-06-11
ZA9711101B (en) 1998-12-10
SK75099A3 (en) 2000-01-18

Similar Documents

Publication Publication Date Title
JP4102440B2 (ja) 新規なエリスロマイシン誘導体、それらの調製方法及びそれらの医薬品としての使用
US6420538B1 (en) Aromatic amides, preparation method and application as medicines
RO115634B1 (ro) Derivati de eritromicina, procedeu de preparare a acestora si compozitie farmaceutica care ii contine
HU219599B (hu) 11,12-Didezoxi-3-dez(2,6-didezoxi-3-C-metil-3-O-metil-alfa-L-ribohexopiranozil-oxi)-6-O-metil-3-oxo-12,11-(oxi-karbonil-((4-(4-(3-piridinil)-1H-imidazol-1-il)-butil)-imino))-eritromicin, előállítása, e vegyületet tartalmazó gyógyászati készítmények ...
KR100587445B1 (ko) 에리트로마이신의 신규한 유도체, 그의 제조 방법 및약제로서의 그의 용도
US6433151B1 (en) Erythromycin derivatives, a process for their preparation and their use as medicaments
SK283715B6 (sk) Deriváty erytromycínu, spôsob a medziprodukty na ich prípravu, ich použitie ako liečiv a farmaceutické kompozície s ich obsahom
KR20020008155A (ko) 리보스로 치환된 신규 방향족 아미드, 그 제조 방법 및의약 용도
JP5188520B2 (ja) 新規なエリスロマイシン誘導体、製造方法及び医薬としての利用
KR100285972B1 (ko) 에리트로마이신 유도체, 그의 제조 방법 및 의약으로서의 용도
KR100458240B1 (ko) 신규 에리트로마이신 유도체, 그의 제조방법 및 의약으로서의용도
US5780604A (en) 11,12-cyclic phosphite or phosphate derivatives of erythromycin and related macrolides
US6706692B1 (en) 6-deoxy erythromycin derivatives, method for preparing same and use as medicines
MXPA99005226A (es) Nuevos derivados de la eritromicina, su procedimiento de preparacion y su aplicacion como medicamentos
MXPA99005840A (es) Derivados novedosos de eritromicina, metodo de preparacion y aplicacion como medicamentos